Food Allergy Epidemiology Research Forecast 2032 – Focus on Germany, Spain, Italy, France, UK, Japan, Canada and China

DUBLIN, April 20, 2022–(BUSINESS WIRE)–“Food Allergy – Epidemiological Forecast – 2032” drug pipelines have been added to from ResearchAndMarkets.com offer.

This ‘Food Allergy-Epidemiology Forecast – 2032’ report provides an in-depth understanding of food allergy, historical and forecast epidemiology in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan, Canada and China.

Food allergy epidemiology

The Food Allergy Epidemiology Division provides historical and current patient pool and predicted trend information for each of the seven major countries. It helps to recognize the causes of current and predicted trends by exploring numerous studies and insights from key opinion leaders. This part of the report also provides the pool of diagnosed patients and their trends as well as the assumptions made.

Main findings

The disease epidemiology covered in the report provides historical and predicted epidemiology of food allergy segmented into prevalent cases of food allergy, prevalent cases of food allergy based on etiology specific factors, prevalence specific to food allergy age. The report includes the prevalent food allergy scenario in 7MM, Canada and China covering the US, EU5 countries (Germany, France, Italy, Spain and UK), Japan, Canada and China from 2019 to 2032.

Country Wise – Food Allergy Epidemiology

The Epidemiology segment also provides epidemiological data and results on food allergies in the United States, EU5 (Germany, France, Italy, Spain and United Kingdom), Japan, Canada and China.

The total prevalent population of associated food allergies in 7MM countries, Canada and China was estimated at 284,023,865 cases in 2019 and is expected to increase at a CAGR of 0.18% for the study period, c i.e. 2019-2032.

  • According to estimates, CN has the most prevalent food allergy population in 7MM, Canada and China.

Among EU-5 countries, Spain had the highest prevalence of food allergies. On the other hand, UK had the lowest number of cases 2,007,094 cases in 2019.

Report scope

  • Food allergy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment regimens.

  • The Food Allergy Epidemiology Report and Model provides an overview of global food allergy risk factors and trends across the top seven markets (7MM: US, France, Germany, Italy, Spain, UK, Japan, Canada and China).

  • The report provides an overview of the historical and projected food allergy patient base in nine major markets spanning the United States, EU5 (Germany, Spain, France, Italy, United Kingdom), Japan, Canada and China.

  • The report helps to recognize growth opportunities in 7MM, Canada and China regarding patient population.

  • The report assesses the risk and burden of disease and highlights the unmet needs of food allergies.

  • The report provides segmentation of food allergy epidemiology by prevalent food allergy cases in 7MM, Canada and China.

  • The report provides segmentation of food allergy epidemiology by prevalent cases of food allergy, prevalent cases of food allergy based on etiology-specific factors, age-specific prevalence of food allergy in 7MM, Canada and China.

Main topics covered:

1. Key information

2. Presentation of the report

3. Food Allergy Market Overview at a Glance

3.1. Market share (%) Breakdown of food allergies in 2019

3.2. Market share (%) Breakdown of food allergies in 2032

4. Food Allergy Executive Summary

5. Background and overview of the disease

5.1. Introduction

5.2. Etiology

5.3. Clinical manifestations

5.4. Food allergy subtypes

5.5. Diagnostic

6. Care and treatment

6.1. Guidelines

6.2. American Guidelines for the Diagnosis and Management of Food Allergies

6.3. European Academy of Allergy and Clinical Immunology (EAACI) Guidelines

6.4. Japanese Food Allergy Guidelines

6.4.1. Severity of symptoms and treatment

6.4.1.1. Ranking of severity of symptoms

6.4.1.2. Treatment based on severity of symptoms

6.4.1.3. Assessment of organ-specific symptoms

6.4.2. Management of Anaphylaxis in a Health Care Setting

6.4.2.1. Confirmation of vital signs

6.4.2.2. Ensure personnel and treatment by a team

6.4.2.3. Intramuscular injection of adrenaline

6.4.2.4. Body position of anaphylactic patients

6.4.2.5. Administration of oxygen

6.4.2.6. Securing the intravenous infusion line and rapid rehydration

6.4.2.7. Stopping breathing

6.4.2.8. Measurement of vital signs: reassessment

6.4.3. Contraindication of adrenaline

7. Epidemiology and patient population

7.1. Main conclusions

7.2. 7MM, total patient population with food allergy prevalent in Canada and China

7.3. Assumption and rationale

7.4. United States

7.4.1. Widespread cases of food allergy in the United States

7.4.2. Prevalent cases of food allergy based on etiology-specific factors in the United States

7.4.3. Age-specific prevalence of food allergies in the United States

7.5. EU5

7.6. Japan

7.7. Canada

7.8. China

8. Patient journey

For more information about this Drug Pipelines report, visit https://www.researchandmarkets.com/r/364pu3

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220420005619/en/

contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Officer
press@researchandmarkets.com
For EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900